Recently, the field of lncRNAs has attracted significant attention, and numerous studies have revealed that PCAT6 expression is up-regulated in various cancers, and that PCAT6 has the potential to become a new diagnostic biomarker and therapeutic target. The gene discussed is PCAT6; the disease is cancer.